COVID-19 vaccination: FG, WHO declares no deaths, blood clot recorded in Nigeria

The Federal Government and the World Health Organisation (WHO) declared on Friday that since it began COVID-19 vaccination with AstraZeneca vaccine on the 15th of March 2021, there has been no report of deaths and blood clotting across the country.

The government however stated that a total of 8,439 mild adverse events following immunisation (AEFI) have been reported, such as pain, swelling at the site of the inoculation, body pains, and nausea. Also, 52 cases of moderate to severe incidents of AEFI have been reported, such as fever, vomiting, diarrhea, headaches, dizziness, and allergic reactions.

It further revealed that five states have the highest records of the AEFI, namely: Kaduna (970) Cross River (859), Yobe (541), Kebbi (511), and Lagos (448).

The Executive Director/Chief Executive Officer of the National Primary Health Care Development Agency (NPHCDA), Dr. Faisal Shuaib, made these known in Abuja at a press briefing on updates on the status of COVID-19 vaccination.

He said: “In Nigeria, since the vaccination program was officially rolled out on 15th of March 2021, a total of 8,439 mild Adverse Events Following Immunisation (AEFI) have been reported. These range from pain, swelling at the site of the inoculation, to body pains and nausea. Similarly, 52 cases of moderate to severe incidents of AEFI have been reported. These are presented as fever, vomiting, diarrhea, headaches, dizziness and allergic reactions. Five states have the highest records of the AEFI namely: Kaduna (970) Cross River (859), Yobe (541), Kebbi (511), and Lagos (448).

“There has been no death from administration of the vaccine. We have also not diagnosed any case of blood clots related to the administration of the vaccines. Nevertheless, we are working with NAFDAC, NCDC and other relevant agencies to set up a more active surveillance system built on our experience with polio surveillance,” he said.

 73 total views,  1 views today

LEAVE A REPLY

Please enter your comment!
Please enter your name here